Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
NIH leadership detailed unprecedented initiative to ramp up testing technologies for COVID-19
On Jul. 22, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…
RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
Findings from real-world data study reveal higher risk of hospitalization and death among cancer patients with COVID-19
On Jul. 22, 2020, the FDA announced the data analyzed in collaboration with Syapse revealed a stark reality…
COVID-19 antibodies decay quickly after mild illness
On Jul. 22, 2020, University of California at Los Angeles researchers reported that they found. levels of antibodies…
COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
On Jul. 22, 2020, the WHO and UNICEF announced the COVID-19 Law Lab initiative which will gather and…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Vaccine
University of British Columbia scientists sequence genomes of Canadians with COVID-19
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
Preclinical study showed SARS-CoV-2 spike protein licensed by Oragenics from NIH produces neutralizing antibodies
On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDﾙ single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneﾒs single-dose intranasal vaccine…
BD received FDA approval for HPV test with extended genotyping capabilities
On Jul. 22, 2020, BD (Becton, Dickinson) announced that it had received approval for a pre-market approval (PMA)…
Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
On Jul. 22, 2020, a new study led by Albert Einstein College of Medicine and Montefiore Health System…
Secrets of naked mole-rat cancer resistance unearthed
On Jul. 21, 2020, researchers at the University of Cambridge have shown for the first time that genes…
Experimental Coronavirus vaccine is safe and produced immune response
On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…
PerkinElmer released new dried blood spot based COVID-19 serology test
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
GSK and CureVac announced strategic mRNA technology collaboration
On Jul. 21, 2020, GlaxoSmithKline and CureVac announced a strategic collaboration agreement for the research, development, manufacturing and…
Experimental coronavirus vaccine reported safe and produces immune response
On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…
Mesa Biotech received $15.4 million funding from the NIH for accelerated scale-up and deployment
On Jul. 21, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples
On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…
COVID-19 vaccine trials conducted at Washington University, Saint Louis University
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
On Jul. 20, 2020, interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed…
FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19
On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…
Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countries
On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…
Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study
On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines
On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…
Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPﾮ…